Atovaquone, Proguanil Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Atovaquone, Proguanil Hydrochloride
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Atovaquone, Proguanil Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 10 USDMF, 4 CEP/COS, 3 EU WC, 6 NDC API, 4 Listed Suppliers, $ API Reference Price

14 API Suppliers
10 USDMF
4 CEP/COS
3 EU WC
6 NDC API
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

37 FDF Dossiers, 6 FDA Orange Book, 13 Europe, 6 Canada, 11 South Africa, 1 Listed Dossiers

37 FDF Dossiers
6 FDA Orange Book
13 Europe
6 Canada
11 South Africa
1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG;100MG, TABLET;ORAL - 62.5MG;25MG

TABLET;ORAL - 250MG;100MG
TABLET;ORAL - 62.5MG;25MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 6 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 23 BASF, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 28 Disintegrants & Superdisintegrants, 25 Granulation, 23 Direct Compression, 22 Thickeners and Stabilizers, 21 Controlled & Modified Release, 15 Solubilizers, 12 Lubricants & Glidants, 10 Co-Processed Excipients, 10 Topical, 9 Film Formers & Plasticizers, 8 Chewable & Orodispersible Aids, 5 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 5 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Taste Masking, 2 Surfactant & Foaming Agents

44 Fillers, Diluents & Binders
41 Coating Systems & Additives
28 Disintegrants & Superdisintegrants
25 Granulation
23 Direct Compression
22 Thickeners and Stabilizers
21 Controlled & Modified Release
15 Solubilizers
12 Lubricants & Glidants
10 Co-Processed Excipients
10 Topical
9 Film Formers & Plasticizers
8 Chewable & Orodispersible Aids
5 Parenteral
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
5 Emulsifying Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 Taste Masking
2 Surfactant & Foaming Agents

DIGITAL CONTENT

3 News #PharmaBuzz

3 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 12 Regulatory FDF Prices

5 US Medicaid Prescriptions
12 Regulatory FDF Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 9 Others

1 EDQM
9 Others

$ API Ref.Price (USD/KG) : 340 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4GlaxoSmithKline Inc.

filter Patent Reset all filters

4 All

01 22150234

02 22152615

filter Product Reset all filters

4 All

01 4Atovaquone | Proguanil Hydrochloride

filter Dosage Reset all filters

4 All

01 4Tablet

filter Exp Date Reset all filters

4 All

01 22013-11-25

02 22013-12-23

Product Main Page

01

GlaxoSmithKline Inc.

Atovaquone, Proguanil

Peptide Process CMC

Not Confirmed

GlaxoSmithKline Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Atovaquone, Proguanil

Brand Name : MALARONE

Patent Number : 2152615

Filing Date : 1993-12-23

Strength per Unit : 250mg Atovaquone / 100mg Proguanil Hydrochloride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Atovaquone, Proguanil

Peptide Process CMC

Not Confirmed

GlaxoSmithKline Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Atovaquone, Proguanil

Brand Name : MALARONE PEDIATRIC

Patent Number : 2150234

Filing Date : 1993-11-25

Strength per Unit : 62.5mg / 25mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Atovaquone, Proguanil

Peptide Process CMC

Not Confirmed

GlaxoSmithKline Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Atovaquone, Proguanil

Brand Name : MALARONE PEDIATRIC

Patent Number : 2152615

Filing Date : 1993-12-23

Strength per Unit : 62.5mg / 25mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Atovaquone, Proguanil

Peptide Process CMC

Not Confirmed

GlaxoSmithKline Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Atovaquone, Proguanil

Brand Name : MALARONE

Patent Number : 2150234

Filing Date : 1993-11-25

Strength per Unit : 250mg Atovaquone / 100mg Proguanil Hydrochloride

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-11-25

Date Granted : 2005-03-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!